To explore the need to sub-divide stage 2 of cervical cancer based on measurement of parametrial (space around cervix) invasion using MRI

To explore the need to sub classify stage IIB cervical cancer based on measurement of parametrial invasion using MRI: Observational study

Status

Active, not recruiting

Phases

Phase 2

Study type

Observational

Source

CTRI

Registry ID

CTRI/2022/04/042254

Enrollment

100

Registered

2022-04-28

Start date

Unknown

Completion date

Unknown

Last updated

2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C538- Malignant neoplasm of overlappingsites of cervix uteri

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Histopathologically proven carcinoma cervix patients deemed fit for radical treatment with either radical radiation or concurrent chemoradiation. 2. Stage IIB confirmed on pelvic MRI done as a part of initial investigation 3. Performance status, Eastern Cooperative Oncology Group (ECOG) 0-1

Exclusion criteria

Exclusion criteria: 1. Patients not fit for radical treatment. 2. Patients not willing for radical treatment or regular follow up. 3. Any contraindication for MRI

Design outcomes

Primary

Measure	Time frame
Overall survival and Disease free survivalTimepoint: median follow up of 3 years.	—

Secondary

Measure	Time frame
Acute gastrointestinal and genitourinary toxicities using CTCAE ver4.0 gradingTimepoint: Within 90 days of completion of radical treatment.;Late gastrointestinal and genitourinary toxicities using CTCAE 4.0 gradingTimepoint: 90 days after completion of radical treatment;Proportion of patients with partial and complete responseTimepoint: at 90 days after completion of radical treatment	—

Countries

India

Contacts

Public ContactRahatdeep Singh Brar

Homi Bhabha Cancer Hospial, Sangrur

brar.rahat@gmail.com01672-223910

Outcome results